Everyone should have access to innovative therapies that represent the promise of lasting cures. At Theolytics we are working to transform patients' lives, through world leading science, with a great team. Our team combines world leading scientific expertise -- spanning virology, cancer biology, immunology, bioinformatics, and molecular biology -- with a track record of translating viral therapies from discovery through to commercial approval.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Charlotte Casebourne

Chief Financial Officer

Andrew Oakley

Chief Operating Officer

Matt Hayman

Chief Operating Officer

Rose McGovern

Co-Founder

Len Seymour

Controller

Luke Harris

Vice President

Miriam Bazan-Peregrino

VP - R & D

Kerry Fisher

VP - Regulatory Affairs

Rosie Ackerman-Johnson

Browse more venture capital transactions:

Prev: 4/17/2024: Toku venture capital transaction
Next: 4/17/2024: Iceye venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary